Panel: Regulating Artificial Intelligence – The AI Act and its Implications
summary
Panel summarizes concrete frictions in the AI Act: one medical firm reports 60 AI-enabled products already CE‑marked under the Medical Devices Regulation, insurers warn existing risk systems should integrate rather than duplicate, and engineers say human oversight breaks down for high‑speed lab automation while remaining essential for diagnostic decision‑support. Reading articles 8–15 consumes real time — about 15 hours of workshops to parse requirements — and regulators debate timelines, calling two years too short and pushing harmonized standards plus clearer Article 11 duties.
AI-written summary · about
chapters (7)
- 0:00Start
- 0:12The Ai Act
- 0:42The Artificial Intelligence Act
- 18:42General Purpose Ai
- 24:43Human Oversight
- 26:53What Is the Role of the State as a Regulator or Legislator
- 44:13Do We Need a Formal Stakeholder Involvement in the Ai Board
related talks
31mPanel: Navigating the AI Policy Landscape
01h 08mTHE GOVERNANCE OF AI: CONVERGENCE OR DIVERGENCE?
01h 06mEMPOWERING THE AI ACT: LIMITS AND OPPORTUNITIES
15mThe AI Act: Striking a Deal & Beyond
01h 19mBridging the Regulatory Gaps for AI Medical Devices The New Layer ...
28mAI Act - What is important to know from a developers perspective?
01h 08mAI Act in Action Compliance, Oversight, and Enforcement
01h 19mPower, Convenience, and Prestige in the Governance and Legal Regulation of AI